Clinical trial
Clinical Evaluation of the Sorin Group's REPLY MR-conditional Pacing System
NCT01341522 is registered in ClinicalTrials.gov with LivaNova as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Clinical Evaluation of the Sorin Group's REPLY MR-conditional Pacing System
- Lead sponsor
- LivaNova
- Phase
- Phase 3
- Overall status
- Withdrawn
- Start date
- January 31, 2012
- Completion date
- May 31, 2013
- Enrollment
- 0 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
dual-chamber pacemaker placement